![]() |
Name |
1-Nonadecene
|
Molecular Formula | C19H38 | |
IUPAC Name* |
nonadec-1-ene
|
|
SMILES |
CCCCCCCCCCCCCCCCCC=C
|
|
InChI |
InChI=1S/C19H38/c1-3-5-7-9-11-13-15-17-19-18-16-14-12-10-8-6-4-2/h3H,1,4-19H2,2H3
|
|
InChIKey |
NHLUYCJZUXOUBX-UHFFFAOYSA-N
|
|
Synonyms |
1-NONADECENE; 18435-45-5; Nonadec-1-ene; Nonadecene; 41F44CP2NI; NSC-77135; UNII-41F44CP2NI; EINECS 242-313-7; EINECS 248-442-5; NSC 77135; 27400-77-7; AI3-36475; DTXSID0066377; CHEBI:64503; 3-(Cyclopentyloxy)-4-methoxyphenol; NSC77135; LMFA11000322; MFCD00009010; ZINC85599377; AKOS028108410; 1-Nonadecene, Standard Material for GC; BS-22718; DB-044527; CS-0196916; FT-0608162; S0349; T71983; 1-NONADECENE [STANDARD MATERIAL FOR GC]; J-011814; Q27133324
|
|
CAS | 18435-45-5 | |
PubChem CID | 29075 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 266.5 | ALogp: | 10.6 |
HBD: | 0 | HBA: | 0 |
Rotatable Bonds: | 16 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 0.0 | Aromatic Rings: | 0 |
Heavy Atoms: | 19 | QED Weighted: | 0.199 |
Caco-2 Permeability: | -4.88 | MDCK Permeability: | 0.00000908 |
Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.162 |
30% Bioavailability (F30%): | 0.902 |
Blood-Brain-Barrier Penetration (BBB): | 0.095 | Plasma Protein Binding (PPB): | 100.46% |
Volume Distribution (VD): | 3.372 | Fu: | 1.04% |
CYP1A2-inhibitor: | 0.182 | CYP1A2-substrate: | 0.178 |
CYP2C19-inhibitor: | 0.331 | CYP2C19-substrate: | 0.063 |
CYP2C9-inhibitor: | 0.091 | CYP2C9-substrate: | 0.949 |
CYP2D6-inhibitor: | 0.342 | CYP2D6-substrate: | 0.173 |
CYP3A4-inhibitor: | 0.376 | CYP3A4-substrate: | 0.047 |
Clearance (CL): | 4.345 | Half-life (T1/2): | 0.047 |
hERG Blockers: | 0.181 | Human Hepatotoxicity (H-HT): | 0.007 |
Drug-inuced Liver Injury (DILI): | 0.058 | AMES Toxicity: | 0.011 |
Rat Oral Acute Toxicity: | 0.025 | Maximum Recommended Daily Dose: | 0.042 |
Skin Sensitization: | 0.97 | Carcinogencity: | 0.046 |
Eye Corrosion: | 0.995 | Eye Irritation: | 0.946 |
Respiratory Toxicity: | 0.276 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000283 | ![]() |
0.945 | D00AOJ | ![]() |
0.627 | ||
ENC000557 | ![]() |
0.891 | D07ILQ | ![]() |
0.597 | ||
ENC000715 | ![]() |
0.859 | D0Z5SM | ![]() |
0.535 | ||
ENC000425 | ![]() |
0.836 | D00FGR | ![]() |
0.529 | ||
ENC000755 | ![]() |
0.786 | D0O1PH | ![]() |
0.494 | ||
ENC000400 | ![]() |
0.783 | D05ATI | ![]() |
0.457 | ||
ENC000486 | ![]() |
0.783 | D0Z5BC | ![]() |
0.400 | ||
ENC000573 | ![]() |
0.782 | D00STJ | ![]() |
0.385 | ||
ENC000723 | ![]() |
0.758 | D0T9TJ | ![]() |
0.354 | ||
ENC000284 | ![]() |
0.746 | D0P1RL | ![]() |
0.340 |